875 related articles for article (PubMed ID: 22932189)
1. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
[TBL] [Abstract][Full Text] [Related]
2. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
[TBL] [Abstract][Full Text] [Related]
3. CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial.
Wildner D; Bernatik T; Greis C; Seitz K; Neurath MF; Strobel D
Ultraschall Med; 2015 Apr; 36(2):132-9. PubMed ID: 25812115
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of regenerative nodule, dysplastic nodule, and small hepatocellular carcinoma in cirrhotic patients: a contrast-enhanced ultrasound-based multivariable model analysis.
Duan Y; Xie X; Li Q; Mercaldo N; Samir AE; Kuang M; Lin M
Eur Radiol; 2020 Sep; 30(9):4741-4751. PubMed ID: 32307563
[TBL] [Abstract][Full Text] [Related]
5. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of contrast-enhanced ultrasound for diagnosis of dysplastic nodules with a focus of hepatocellular carcinoma in liver cirrhosis patients.
Wu W; Chen M; Yan K; Dai Y; Yin S; Yang W; Fan Z
Chin J Cancer Res; 2015 Feb; 27(1):83-9. PubMed ID: 25717230
[TBL] [Abstract][Full Text] [Related]
7. Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
Quaia E; De Paoli L; Angileri R; Pizzolato R; Cabibbo B; Cova MA
Abdom Imaging; 2013 Dec; 38(6):1245-53. PubMed ID: 24026173
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound.
Kim TK; Lee KH; Khalili K; Jang HJ
Abdom Imaging; 2011 Jun; 36(3):244-63. PubMed ID: 21253723
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
[TBL] [Abstract][Full Text] [Related]
10. Characterization of dysplastic nodules, early hepatocellular carcinoma and progressed hepatocellular carcinoma in cirrhosis with contrast-enhanced ultrasound.
Giorgio A; Calisti G; di Sarno A; Farella N; de Stefano G; Scognamiglio U; Giorgio V
Anticancer Res; 2011 Nov; 31(11):3977-82. PubMed ID: 22110230
[TBL] [Abstract][Full Text] [Related]
11. Small nodules (1-2 cm) in liver cirrhosis: characterization with contrast-enhanced ultrasound.
Jang HJ; Kim TK; Wilson SR
Eur J Radiol; 2009 Dec; 72(3):418-24. PubMed ID: 18834687
[TBL] [Abstract][Full Text] [Related]
12. Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent.
Xu HX; Liu GJ; Lu MD; Xie XY; Xu ZF; Zheng YL; Liang JY
J Clin Ultrasound; 2006; 34(6):261-72. PubMed ID: 16788957
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
Forner A; Vilana R; Ayuso C; Bianchi L; Solé M; Ayuso JR; Boix L; Sala M; Varela M; Llovet JM; Brú C; Bruix J
Hepatology; 2008 Jan; 47(1):97-104. PubMed ID: 18069697
[TBL] [Abstract][Full Text] [Related]
14. Contrast-Enhanced Ultrasound to Monitor Early Recurrence of Primary Hepatocellular Carcinoma after Curative Treatment.
Liu LF; Ding ZL; Zhong JH; Li HX; Liu JJ; Li H; Li LQ
Biomed Res Int; 2018; 2018():8910562. PubMed ID: 30533441
[TBL] [Abstract][Full Text] [Related]
15. Contrast-Enhanced Ultrasound With Perfluorobutane for Hepatocellular Carcinoma Diagnosis: Comparison of Imaging Phases and Diagnostic Criteria.
Kang HJ; Lee JM; Yoon JH; Yoo J; Kim JH; Park J
AJR Am J Roentgenol; 2024 Feb; 222(2):e2330156. PubMed ID: 37991335
[No Abstract] [Full Text] [Related]
16. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium.
Hayashi M; Matsui O; Ueda K; Kawamori Y; Kadoya M; Yoshikawa J; Gabata T; Takashima T; Nonomura A; Nakanuma Y
AJR Am J Roentgenol; 1999 Apr; 172(4):969-76. PubMed ID: 10587130
[TBL] [Abstract][Full Text] [Related]
17. Use of vessel patterns on contrast-enhanced ultrasonography using a perflubutane-based contrast agent for the differential diagnosis of regenerative nodules from early hepatocellular carcinoma or high-grade dysplastic nodules in patients with chronic liver disease.
Numata K; Fukuda H; Nihonmatsu H; Kondo M; Nozaki A; Chuma M; Morimoto M; Oshima T; Okada M; Murakami T; Takebayashi S; Maeda S; Inayama Y; Nakano M; Tanaka K
Abdom Imaging; 2015 Oct; 40(7):2372-83. PubMed ID: 26099473
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of hepatocellular carcinoma nodules in patients with chronic liver disease using contrast-enhanced sonography: usefulness of the combination of arterial- and kupffer-phase enhancement patterns.
Suzuki K; Okuda Y; Ota M; Kojima F; Horimoto M
J Ultrasound Med; 2015 Mar; 34(3):423-33. PubMed ID: 25715363
[TBL] [Abstract][Full Text] [Related]
19. Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2 cm.
Forner A; Vilana R; Bianchi L; Rodríguez-Lope C; Reig M; García-Criado MÁ; Rimola J; Solé M; Ayuso C; Bru C; Bruix J
J Hepatol; 2015 Jan; 62(1):150-5. PubMed ID: 25173969
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced ultrasound (CEUS) for differentiating between hepatocellular and cholangiocellular carcinoma.
Bohle W; Clemens PU; Heubach T; Zoller WG
Ultraschall Med; 2012 Dec; 33(7):E191-E195. PubMed ID: 22194045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
